Skip to main content
. 2021 Feb 12;11:608279. doi: 10.3389/fphys.2020.608279

FIGURE 6.

FIGURE 6

Combination treatment reversed the dysbiosis in GVHD mice on the species level. (A) The UPGMA tree of the top 10 species in abundance based on weighted UniFrac distances in the species level. The relative abundances of enteric bacteria at the species level in different groups of mice were assessed using 16S high-throughput sequencing after BMT on day 7. n = 4–6/group. (B) The statistical analysis of the abundance of top 35 species in gut microbiota between different groups of mice. n = 4–6/group. The heat map is color-based on row Z scores. The groups with the highest and lowest bacterial level are marked in red and blue, respectively. The combination treatment significantly down-regulated the relative abundance of E. coli and Enterococcus durans. (C–J) Cladograms (C,E,G,I) and LDA (linear discriminant analysis) score (D,F,H,J) generated by LEfSe (linear discriminant analysis effect size) indicating differences in bacterial taxa in different groups of mice 7 days after the BMT. n = 4–6/group. The central point represents the root of the tree (bacteria), and each ring represents the next lower taxonomic level (from phylum to genus). The diameter of each circle represents the relative abundance of the taxon. Only the taxa meeting a significant LDA threshold value of >2 are shown. The species in the non-transplant group (ATCON) and the combo treatment group (ATCOM) were indicated with a negative LDA score (D,J). (C,D) LEfSe analysis of the ATCON vs. the GVHD group. The potential biomarkers of the GVHD group: (1). Proteobacteria, Gammaproteobacteria, Enterobacteriales, Enterobacteriaceae, unidentified Enterobacteriaceae, E. coli; (2). Firmicutes, Bacilli, Lactobacillales, Enterococcaceae, Enterococcus, E. durans. The potential biomarkers of the ATCON group: (1). Bacteroidetes, Bacteroidia, Bacteroidales, Rikenellaceae, Alistipes; (2). Firmicutes, Clostridia, Clostridiales, Ruminococcaceae, unidentified Ruminococcaceae, Clostridium papyrosolvens; (3). Verrucomicrobia, Verrucomicrobiae, Verrucomicrobiales, Akkermansiaceae, Akkermansia. (E,F) The LEfSe analysis of the GVHD vs. the CSA group. (G,H) The LEfSe analysis of the GVHD vs. the 0.2 mL/kg XBJ-treated group. (I,J) The LEfSe analysis of the GVHD vs. COM group.